PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $27,667,000 | -12.7% | 564,579 | -12.1% | 0.72% | -18.4% |
| Q1 2018 | $31,700,000 | -54.5% | 642,179 | -20.1% | 0.89% | -61.5% |
| Q4 2017 | $69,628,000 | -68.5% | 803,820 | -56.5% | 2.31% | -45.4% |
| Q3 2017 | $221,254,000 | +245.2% | 1,847,640 | +152.0% | 4.22% | +31.0% |
| Q2 2017 | $64,092,000 | +28385.3% | 733,320 | +9885.3% | 3.22% | +20056.2% |
| Q4 2016 | $225,000 | -54.3% | 7,344 | 0.0% | 0.02% | -50.0% |
| Q3 2016 | $492,000 | -95.8% | 7,344 | -92.7% | 0.03% | -95.4% |
| Q2 2015 | $11,675,000 | +344.9% | 100,000 | +809.1% | 0.70% | +149.3% |
| Q3 2014 | $2,624,000 | +3352.6% | 11,000 | +1396.6% | 0.28% | +3425.0% |
| Q1 2014 | $76,000 | 0.0% | 735 | 0.0% | 0.01% | -11.1% |
| Q4 2013 | $76,000 | – | 735 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |